Sergio Buccheri
A5066308149- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Infective Endocarditis Diagnosis and Management
- Cardiac Structural Anomalies and Repair
- Venous Thromboembolism Diagnosis and Management
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Hemodynamic Monitoring and Therapy
- Statistical Methods in Clinical Trials
- Meta-analysis and systematic reviews
- Diabetes Treatment and Management
- Cardiac Arrhythmias and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Effects of Exercise
- Peripheral Artery Disease Management
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Disease and Adiposity
- Intellectual Property and Patents
Uppsala University
2018-2025
University of Catania
2012-2024
Policlinico Universitario di Catania
2013-2024
Uppsala University Hospital
2021-2023
Ferrarotto Hospital
2015-2019
Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele
2017-2019
Surgical Specialties (United States)
2018
Presidio Ospedaliero
2018
Deutsches Herzzentrum München
2017
Technical University of Munich
2017
Poland), and Katja Zeppenfeld (
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The majority of transcatheter aortic valve implantation (TAVI) procedures are currently performed by percutaneous transfemoral approach. potential contribution the type vascular closure device to incidence complications is not clear. To compare efficacy a Prostar XL- vs. Perclose ProGlide-based strategy. ClOsure iN TRansfemoral aOrtic vaLve (CONTROL) multi-center study included 3138 consecutive TAVI patients, categorized according strategy: (Prostar group) strategy (ProGlide group)....
Background Long-term data on durability of currently available transcatheter heart valves are sparse. We sought to assess the incidence long-term (8-year) structural valve dysfunction and bioprosthetic failure in a cohort patients with aortic replacement ( TAVR ) who reached at least 5-year follow-up. Methods Results Consecutive follow-up undergoing from June 4, 2007 March 30, 2012 were included. Structural defined according newly standardized European Association Percutaneous Cardiovascular...
The level of evidence (LOE) grading system for ESC Clinical Practice Guidelines classifies the quality supporting a recommendation. However, current taxonomy does not fully consider optimal study design necessary to establish such recommendations. Therefore, two separate taskforces clinical and methodological experts were appointed by Committee, with first tasked updating LOE therapy prevention, second responsible developing diagnosis prediction. updated prevention presented here maintains...
Initial data about the performance of new-generation SAPIEN 3 Ultra (S3U) valve are highly promising. However, evidence longer-term and safety S3U is scarce.
In recent years, transcatheter aortic valve implantation (TAVI) has rapidly emerged as a key treatment option for stenosis. TAVI been performed at Uppsala University Hospital since 2009. Data on procedures have collected in nation-wide all-comer registry, the Swedish Transcatheter Cardiac Intervention Registry (SWENTRY). However, only limited analysis conducted trends short- and long-term outcomes of patients Sweden. This registry-based cohort study aims to evaluate outcome prognosis who...
We sought to describe an optimized approach coronary artery disease (CAD) screening and management in patients undergoing transcatheter aortic valve replacement (TAVR).When invasive angiography showed CAD, the treatment strategy completeness of revascularization was determined based on anatomy. TAVR performed same setting if percutaneous intervention (PCI) uncomplicated; otherwise postponed. A total 604 CAD at time procedure were prospectively included this study. Severe found 136 (22.5%)....
Abstract Aims To evaluate outcomes of transfemoral transcatheter aortic valve implantation (TF‐TAVI) using three different new‐generation devices. Background Although new generation valves (TAVs) have demonstrated to improve procedural outcomes, date few head‐to‐head comparisons are available among these Methods This is a single center, retrospective study. From September 2014 February 2018, 389 patients underwent elective TF‐TAVI for native, severe stenosis (TAV) with preprocedural...